Logo image of IFX.DE

INFINEON TECHNOLOGIES AG (IFX.DE) Stock Fundamental Analysis

FRA:IFX - Deutsche Boerse Ag - DE0006231004 - Common Stock - Currency: EUR

37.84  +0.49 (+1.3%)

Fundamental Rating

4

Overall IFX gets a fundamental rating of 4 out of 10. We evaluated IFX against 54 industry peers in the Semiconductors & Semiconductor Equipment industry. IFX has a medium profitability rating, but doesn't score so well on its financial health evaluation. IFX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IFX was profitable.
In the past year IFX had a positive cash flow from operations.
Each year in the past 5 years IFX has been profitable.
IFX had a positive operating cash flow in each of the past 5 years.
IFX.DE Yearly Net Income VS EBIT VS OCF VS FCFIFX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.67%, IFX is doing worse than 81.48% of the companies in the same industry.
The Return On Equity of IFX (4.52%) is worse than 75.93% of its industry peers.
With a Return On Invested Capital value of 5.51%, IFX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
IFX had an Average Return On Invested Capital over the past 3 years of 11.24%. This is significantly below the industry average of 16.29%.
The 3 year average ROIC (11.24%) for IFX is well above the current ROIC(5.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.67%
ROE 4.52%
ROIC 5.51%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
IFX.DE Yearly ROA, ROE, ROICIFX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of IFX (5.28%) is worse than 81.48% of its industry peers.
IFX's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 11.18%, IFX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of IFX has grown nicely.
With a Gross Margin value of 39.66%, IFX is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
IFX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.18%
PM (TTM) 5.28%
GM 39.66%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
IFX.DE Yearly Profit, Operating, Gross MarginsIFX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

IFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for IFX has been reduced compared to 1 year ago.
IFX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IFX has a worse debt to assets ratio.
IFX.DE Yearly Shares OutstandingIFX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IFX.DE Yearly Total Debt VS Total AssetsIFX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

IFX has an Altman-Z score of 3.70. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
IFX's Altman-Z score of 3.70 is on the low side compared to the rest of the industry. IFX is outperformed by 70.37% of its industry peers.
IFX has a debt to FCF ratio of 8.00. This is a slightly negative value and a sign of low solvency as IFX would need 8.00 years to pay back of all of its debts.
IFX's Debt to FCF ratio of 8.00 is on the low side compared to the rest of the industry. IFX is outperformed by 61.11% of its industry peers.
IFX has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
IFX has a Debt to Equity ratio (0.32) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 8
Altman-Z 3.7
ROIC/WACC0.53
WACC10.34%
IFX.DE Yearly LT Debt VS Equity VS FCFIFX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.99 indicates that IFX should not have too much problems paying its short term obligations.
The Current ratio of IFX (1.99) is worse than 61.11% of its industry peers.
A Quick Ratio of 1.09 indicates that IFX should not have too much problems paying its short term obligations.
The Quick ratio of IFX (1.09) is worse than 68.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.09
IFX.DE Yearly Current Assets VS Current LiabilitesIFX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for IFX have decreased strongly by -29.52% in the last year.
Measured over the past years, IFX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.75% on average per year.
The Revenue has decreased by -6.02% in the past year.
Measured over the past years, IFX shows a quite strong growth in Revenue. The Revenue has been growing by 13.25% on average per year.
EPS 1Y (TTM)-29.52%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-19.05%
Revenue 1Y (TTM)-6.02%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%-1.13%

3.2 Future

The Earnings Per Share is expected to grow by 10.26% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.86% on average over the next years.
EPS Next Y-14.23%
EPS Next 2Y8.38%
EPS Next 3Y12.89%
EPS Next 5Y10.26%
Revenue Next Year0.27%
Revenue Next 2Y5.38%
Revenue Next 3Y6.89%
Revenue Next 5Y6.86%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IFX.DE Yearly Revenue VS EstimatesIFX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IFX.DE Yearly EPS VS EstimatesIFX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.65, the valuation of IFX can be described as rather expensive.
62.96% of the companies in the same industry are more expensive than IFX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IFX to the average of the S&P500 Index (27.51), we can say IFX is valued inline with the index average.
The Price/Forward Earnings ratio is 17.23, which indicates a rather expensive current valuation of IFX.
Based on the Price/Forward Earnings ratio, IFX is valued a bit cheaper than 72.22% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IFX to the average of the S&P500 Index (35.58), we can say IFX is valued rather cheaply.
Industry RankSector Rank
PE 23.65
Fwd PE 17.23
IFX.DE Price Earnings VS Forward Price EarningsIFX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IFX's Enterprise Value to EBITDA ratio is in line with the industry average.
IFX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 67.14
EV/EBITDA 14.8
IFX.DE Per share dataIFX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

IFX's earnings are expected to grow with 12.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.5
EPS Next 2Y8.38%
EPS Next 3Y12.89%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.91%, IFX is not a good candidate for dividend investing.
IFX's Dividend Yield is a higher than the industry average which is at 1.19.
Compared to an average S&P500 Dividend Yield of 2.35, IFX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of IFX is nicely growing with an annual growth rate of 6.41%!
Dividend Growth(5Y)6.41%
Div Incr Years3
Div Non Decr Years4
IFX.DE Yearly Dividends per shareIFX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

58.86% of the earnings are spent on dividend by IFX. This is a bit on the high side, but may be sustainable.
IFX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.86%
EPS Next 2Y8.38%
EPS Next 3Y12.89%
IFX.DE Yearly Income VS Free CF VS DividendIFX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
IFX.DE Dividend Payout.IFX.DE Dividend Payout, showing the Payout Ratio.IFX.DE Dividend Payout.PayoutRetained Earnings

INFINEON TECHNOLOGIES AG

FRA:IFX (7/15/2025, 12:16:20 PM)

37.84

+0.49 (+1.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-05 2025-08-05/amc
Inst Owners46.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.42B
Analysts81.88
Price Target40.44 (6.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0.35
Dividend Growth(5Y)6.41%
DP58.86%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.56%
Min EPS beat(2)3.19%
Max EPS beat(2)23.94%
EPS beat(4)4
Avg EPS beat(4)7.88%
Min EPS beat(4)1.58%
Max EPS beat(4)23.94%
EPS beat(8)8
Avg EPS beat(8)8.35%
EPS beat(12)12
Avg EPS beat(12)8.65%
EPS beat(16)15
Avg EPS beat(16)9.04%
Revenue beat(2)1
Avg Revenue beat(2)2.41%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)5.55%
Revenue beat(4)1
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)5.55%
Revenue beat(8)2
Avg Revenue beat(8)-0.62%
Revenue beat(12)5
Avg Revenue beat(12)0.22%
Revenue beat(16)8
Avg Revenue beat(16)0.36%
PT rev (1m)0.14%
PT rev (3m)-5.34%
EPS NQ rev (1m)-2.25%
EPS NQ rev (3m)-14.26%
EPS NY rev (1m)0%
EPS NY rev (3m)1.4%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-4.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 23.65
Fwd PE 17.23
P/S 3.38
P/FCF 67.14
P/OCF 14.71
P/B 2.89
P/tB 6.73
EV/EBITDA 14.8
EPS(TTM)1.6
EY4.23%
EPS(NY)2.2
Fwd EY5.8%
FCF(TTM)0.56
FCFY1.49%
OCF(TTM)2.57
OCFY6.8%
SpS11.21
BVpS13.1
TBVpS5.63
PEG (NY)N/A
PEG (5Y)1.5
Profitability
Industry RankSector Rank
ROA 2.67%
ROE 4.52%
ROCE 6.78%
ROIC 5.51%
ROICexc 5.93%
ROICexgc 10.49%
OM 11.18%
PM (TTM) 5.28%
GM 39.66%
FCFM 5.03%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
ROICexc(3y)13.19%
ROICexc(5y)10.13%
ROICexgc(3y)27.93%
ROICexgc(5y)22.61%
ROCE(3y)13.84%
ROCE(5y)10.48%
ROICexcg growth 3Y-5.66%
ROICexcg growth 5Y1.68%
ROICexc growth 3Y6.77%
ROICexc growth 5Y-4.81%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 8
Debt/EBITDA 1.52
Cap/Depr 137.17%
Cap/Sales 17.93%
Interest Coverage 10.16
Cash Conversion 94.67%
Profit Quality 95.21%
Current Ratio 1.99
Quick Ratio 1.09
Altman-Z 3.7
F-Score4
WACC10.34%
ROIC/WACC0.53
Cap/Depr(3y)151.77%
Cap/Depr(5y)128.29%
Cap/Sales(3y)17.6%
Cap/Sales(5y)15.83%
Profit Quality(3y)37.85%
Profit Quality(5y)92.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.52%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-19.05%
EPS Next Y-14.23%
EPS Next 2Y8.38%
EPS Next 3Y12.89%
EPS Next 5Y10.26%
Revenue 1Y (TTM)-6.02%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%-1.13%
Revenue Next Year0.27%
Revenue Next 2Y5.38%
Revenue Next 3Y6.89%
Revenue Next 5Y6.86%
EBIT growth 1Y-48.34%
EBIT growth 3Y20.04%
EBIT growth 5Y16.98%
EBIT Next Year45.14%
EBIT Next 3Y32.02%
EBIT Next 5Y23.64%
FCF growth 1Y-41.96%
FCF growth 3Y-66.12%
FCF growth 5Y-16.47%
OCF growth 1Y-12.66%
OCF growth 3Y-3.2%
OCF growth 5Y11.67%